Mucin 5 AC (MUC5AC) to predict pathologic treatment response (TR) to neoadjuvant chemotherapy (NAT) in resected-pancreatic ductal adenocarcinoma (R-PDA).

Authors :: Manne, Ashish
Sheel, Ankur
Sara, Amir
Noonan, Anne M.
Yu, Lianbo
Yang, Wancai
Hays, John L.
Mittra, Arjun
Malalur, Pannaga G.
Rahman, Shafia
Roychowdhury, Sameek
Elkatib, Rifat
Jin, Ning
Cloyd, Jordan M.
Dillhoff, Mary
Ejaz, Aslam
Esnakula, Ashwini K.
Source :: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p690-690, 117p
Publication Year :: 2024

Full Text Access

Tools